US Patent 8367696 Aza-bridged-ring compound
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+295 characters)
Article
Patent abstract
[PROBLEMS] Provided is a compound which has an antagonistic action on a muscarinic M3 receptor and is useful as an active ingredient of a prophylactic and/or therapeutic agent for an inflammatory disease such as a chronic obstructive pulmonary disease (COPD), asthma and the like.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Hiroshi Nagata0
Hisao Hamaguchi0
Shinya Nagashima0
Tadatsura Koshika0
Toru Kontani0
Yuji Matsushima0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08367696 Aza-bridged-ring compound US Patent 8367696 Aza-bridged-ring compound
Infobox
Patent Number
083676960
Patent Number
83676960
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
083676960
Date of Patent
February 5, 2013
0Patent Application Number
125247580
Date Filed
February 8, 2008
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08367696 Aza-bridged-ring compound
Infobox
Is a
Patent jurisdiction
Patent number
08367696
Date of patent
February 5, 2013
Patent application number
12524758
Date Filed
February 8, 2008
Patent primary examiner
Find more entities like US Patent 8367696 Aza-bridged-ring compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
